| 영문 | vinyl chloride | 한글 | 염화비닐 |
|---|---|---|---|
| 설명 | 주로 공업체의 절연체나, 스프레이, 공업용화학제로 쓰인다. 인체에 암을 유발할 수 있는 발암제로 알려져 있다. |
||
| 영문 | oral administration | 한글 | 경구복용 |
|---|---|---|---|
| 설명 | 약을 투여하는 방법에는 여러 가지가 있다. 크게 나누어 보면, 입을 거쳐 위창자계를 통해 넣는 방법과 위창자계를 통하지 않고 바로 혈액으로 넣는 방법이 있다. 위창자계를 통하지 않는 방법으로 가장 흔한 방법은 주사를 이용하는 방법이다. 하지만, 이외에 항문을 통해 넣는 좌약식방법과 혀밑에 넣는 혀밑투여법도 있다. 그러나 대부분의 약제는 경구복용을 하게 된다. 경구복용에 대한 약자는 p.o.(per oral)로 표기한다. 경구복용제의 단점은 복용한 약제가 위창자관계를 거치면서 사람마다 각기 다른 흡수정도와 대사정도를 거치게 되므로 일정한 농도유지가 어렵다는데 있다. 또한 경구복용제의 모양이 캡슐형인지, 혹은 가루형인지에 따라서도 같은 약이지만, 서로 다른 효과를 나타낼 수 있다. |
||
| 영문 | oral cavity | 한글 | 구강 |
|---|---|---|---|
| 설명 | 입을 벌여서 입속에서 볼 수 있는 공간으로 입천장, 편도, 목젖을 볼 수 있다.  |
||
| 영문 | oral cavity | 한글 | 입안 |
|---|---|---|---|
| 설명 | 입을 벌여서 입속에서 볼 수 있는 공간으로 입천장, 편도, 목젖을 볼 수 있다. |
||
| ORS | olfactory reference syndrome; oral rehydration solution; oral surgery, oral surgeon; Orthopaedic Res... |
|---|---|
| OCP | octacalcium phosphate; ocular cicatricial pemphigoid; oral case presentation; oral contraceptive pil... |
| OET | oral endotracheal tube; oral esophageal tube |
| OHI | Occupational Health Institute; operative hypertension indicator; oral hygiene index; Oral Hygiene In... |
| ACM | acetaminophen; acute cerebrospinal meningitis; Adriamycin, cyclophosphamide, methotrexate; albumin- ... |
| MgCl2 | Magnesium chloride |
|---|---|
| iMg | Ionized magnesium |
| Mg | Magnesium |
| Mg ATP | magnesium adenosine triphosphate |
| MgO | Magnesium oxide |
| magnesium chloride | <chemical> Magnesium chloride. An inorganic compound consisting of one magnesium and two chloride ions. The compound is used in medicine as a source of magnesium ions, which are essential for many cellular activities. It has also been used as a cathartic and in alloys. Chemical name: Magnesium chloride (MgCl2) (12 Dec 1998) |
|---|---|
| aluminum magnesium silicate | An antacid. Synonym: aluminum magnesium silicate. (05 Mar 2000) |
| calcium magnesium-atpase | <enzyme> An enzyme that catalyses the hydrolysis of ATP and is activated by millimolar concentrations of either calcium or magnesium. Unlike calcium-transporting atpase it does not require the second divalent cation for its activity, and is not sensitive to orthovanadate. Registry number: EC 3.6.1.- (12 Dec 1998) |
| calcium magnesium dependent endodeoxyribonuclease | <enzyme> Similar in action but different from dnase i Registry number: EC 3.1.21.- Synonym: ca mg dnase, ca(2+)+mg(2+) dnase, calcium-magnesium endonuclease, ca-mg endonuclease (26 Jun 1999) |
| magnesium | <chemical, element> An essential divalent cation. The major role is as the chelated ion in ATP and presumably other triphosphonucleotides. The magnesium ATP complex is the sole biologically active form of ATP. The other essential role of magnesium is as the central ion of chlorophyll. Cellular concentration is less than 5mM. Serum concentration approximately 1mM. Pharmacologic action: Hypomagnesemia can cause refractory ventricular fibrillation or ventricular tachycardia. Uses: known hypomagnesemic states - suspect hypomagnesmia in alcoholics, chronic disease states, or others with poor nutrition; treatment of choice for Torsade de Pointes. Dose: 1-2 grams IV push for cardiac arrest, over 1 to 2 minutes for Torsades, and over 5 to 60 minutes for acute myocardial infarction. Potential complications: Transient flushing and diaphoresis, sinus bradycardia, hypotension, hyporeflexia and paralysis with overdose. Abbreviation: Mg (15 Mar 2000) |
| magnesium aluminum silicate | An antacid. Synonym: aluminum magnesium silicate. (05 Mar 2000) |
| magnesium bacteriopheophytinate | <microbiology, plant biology> Varieties of chlorophyll (bacteriochlorophylls a, b, c, d, e and g) found in photosynthetic bacteria and differing from plant chlorophyll in the substituents around the tetrapyrrole nucleus of the molecule and in the absorption spectra. (18 Nov 1997) |
| magnesium benzoate | Has been used in gout and rheumatoid arthritis. (05 Mar 2000) |
| magnesium-bicarbonate ATPase | <enzyme> Aspect of EC 3.6.1.3 Registry number: EC 3.6.1.- Synonym: mg-hco3-atpase, atpase, magnesium-bicarbonate (26 Jun 1999) |
| magnesium carbonate | Used in gastric and intestinal acidity and as a laxative. (05 Mar 2000) |
| magnesium chelatase | <enzyme> Catalyses the first committed step in chlorophyll biosynthesis by adding magnesium to protoporphyrin ix Registry number: EC 4.99.1- Synonym: mg-chelatase, magnesium-protoporphyrin chelatase (26 Jun 1999) |
| magnesium citrate | Mg3(C6H5O7)2-14H 2O;a laxative; usually administered as an effervescent flavored beverage. (05 Mar 2000) |
| magnesium compounds | Inorganic compounds that contain magnesium as an integral part of the molecule. (12 Dec 1998) |
| magnesium deficiency | Can occur due to inadequate intake or impaired intestinal absorption of magnesium. Low magnesium (hypomagnesaemia) is often associated with low calcium (hypocalcaemia) and low potassium (hypokalaemia). Deficiency of magnesium causes increased irritability of the nervous system with tetany (spasms of the hands and feet, muscular twitching and cramps, spasm of the larynx, etc.). According to the national academy of sciences, the recommended dietary allowances of magnesium are 420 milligrams per day for men and 320 milligrams per day for women. The upper limit of magnesium as supplements is 350 milligrams daily, in addition to the magnesium from food and water. (12 Dec 1998) |
| magnesium excess | Persons with impaired kidney function should be especially careful about their magnesium intake because they can accumulate magnesium, a dangerous situation. According to the national academy of sciences, the recommended dietary allowances of magnesium are 420 milligrams per day for men and 320 milligrams per day for women. The upper limit of magnesium as supplements is 350 milligrams daily, in addition to the magnesium from food and water. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|